St. Jude study highlights a new potential type of vulnerability in solid tumors that may be targeted to enhance immunotherapy efficacy. (IMAGE)
Caption
(L to R) Corresponding author Hongbo Chi, co-first author Sujing Yuan and co-first author Renqiang Sun, PhD, PhD, St. Jude Department of Immunology.
Credit
Courtesy of St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content